Control | Normal | Acute | 7 Day | 14 Day | 28 Day | |
---|---|---|---|---|---|---|
PSP peak amplitude CB, mV | 24.1 ± 1.9 (11) | 21.5 ± 2.6 (18) | 31.3 ± 4.83-b (10) | 29.2 ± 4.0 (9) | 30.9 ± 4.03-b (15) | 30.9 ± 2.13-b (14) |
PSP peak amplitude NCB, mV | 24.6 ± 1.8 | 26.6 ± 2.5 | 36.2 ± 2.33-a 3-b | 32.8 ± 2.23-a | 31.3 ± 2.43-a | 30.9 ± 2.93-a |
PSP threshold CB, μA | 25.7 ± 4.0 | 20.3 ± 3.5 | 29.3 ± 5.6 | 21.3 ± 2.8 | 26.5 ± 1.7 | 29.1 ± 8.7 |
PSP threshold NCB, μA | 25.9 ± 3.7 | 14.5 ± 3.0 | 17.8 ± 3.1 | 15.2 ± 2.9 | 15.3 ± 2.8 | 14.6 ± 2.5 |
PSP latency CB, ms | 2.4 ± 0.11 | 2.6 ± 0.13 | 2.8 ± 0.31 | 2.7 ± 0.18 | 2.5 ± 0.13 | 2.5 ± 0.11 |
PSP latency NCB, ms | 2.4 ± 0.14 | 2.6 ± 0.13 | 2.7 ± 0.27 | 2.7 ± 0.27 | 2.6 ± 0.13 | 2.5 ± 0.09 |
IPSP peak amplitude CB, mV | 4.6 ± 0.33 (11) | 6.4 ± 0.53 (9) | 7.3 ± 1.03-b (9) | 7.7 ± 0.873-b (10) | 5.8 ± 0.53 (10) | |
IPSP peak amplitude NCB, mV | 5.3 ± 0.44 | 8.2 ± 0.433-b | 8.9 ± 0.733-b 3-e | 6.6 ± 0.80 | 6.1 ± 0.52 | |
IPSP t1/2 CB, ms | 121.3 ± 15.9 | 112.0 ± 13.2 | 190.4 ± 23.13-b 3-c | 173.9 ± 14.23-c | 192.4 ± 17.63-b 3-c | |
IPSP t1/2 NCB, ms | 159.8 ± 17.3 | 145.4 ± 8.6 | 195.4 ± 17.8 | 179.9 ± 15.9 | 192.6 ± 18.2 | |
IPSP threshold CB, μA | 25.3 ± 6.7 | 37.1 ± 10.2 | 31.5 ± 5.6 | 25.2 ± 3.8 | 31.5 ± 9.8 | |
IPSP threshold NCB, μA | 21.7 ± 7.2 | 27.2 ± 8.5 | 22.9 ± 4.1 | 16.1 ± 2.3 | 19.5 ± 1.7 | |
IPSP latency CB, ms | 2.8 ± 0.33 | 2.6 ± 0.42 | 2.8 ± 0.18 | 2.7 ± 0.21 | 2.9 ± 0.29 | |
IPSP latency NCB, ms | 2.7 ± 0.3 | 2.6 ± 0.30 | 2.9 ± 0.16 | 2.7 ± 0.19 | 2.9 ± 0.29 |
-
Values are means ± SE with number of neurons in parentheses. Data categories are as in Table 1 and Figs. 5 and6.
-
↵F3-a Significantly different from control,P < 0.05.
-
↵F3-b Significantly different from normal, P < 0.05.
-
↵F3-c Significantly different from acute,P < 0.05.
-
F3-d Significantly different from 7 day, P < 0.05.
-
↵F3-e Significantly different from 14 day,P < 0.05.
-
F3-f Significantly different from 28 day, P < 0.05.